https://orcid.org/0000-0003-3709-1922
References
- Beck JI, Boothroyd C, and Proctor M, et al. Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst Rev 2005: Art. No.: CD002249, 1–32.
- Viola MI, Meyer D, Kruger T. Association between clomiphene citrate and visual disturbances with special emphasis on central retinal vein occlusion: a review. Gynecol Obstet Invest 2011; 71: 73–76.
- Myers TD, Fraunfelder FW. Bilateral anterior uveitis associated with clomiphene citrate. Ocul Immunol Inflamm 2008; 16: 23–24.
- Racette L, Casson PR, Claman P, et al. An investigation of the visual disturbances experienced by patients on clomiphene citrate. Fertil Steril 2010; 93: 1169–1172.
- Tunc M. Maculopathy following extended usage of clomiphene citrate. Eye 2014; 28: 1144–1146.
- Grossniklaus HE, Green WR. Choroidal neovascularization. Am J Ophthalmol 2004; 137: 496–503.
- Green WR, Wilson DJ. Choroidal neovascularization. Ophthalmol 1986; 93: 1169–1176.
- Wolf S, Balciuniene VJ, Laganovska G, et al. RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmol 2014; 121: 682–692 e682.
- Sagar P, Sodhi PS, and Roy S, et al. Pachychoroid neovasculopathy: a comparative review on pathology, clinical features, and therapy. Eur J Ophthalmol 2021; 32: 767–780.
- Shinkai A, Saito W, Hashimoto Y, et al. Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis. BMC Ophthalmol 2019; 19: 267.